Published in J Cell Physiol on June 01, 2000
Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. Pigment Cell Melanoma Res (2008) 1.37
Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice. Proc Natl Acad Sci U S A (2011) 1.12
Molecular pathways: dysregulated glutamatergic signaling pathways in cancer. Clin Cancer Res (2012) 1.10
Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics (2009) 1.05
Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacology (2008) 1.02
Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells. Oncogene (2012) 1.01
G-protein-coupled receptors and melanoma. Pigment Cell Melanoma Res (2008) 0.97
mGlu Receptors and Cancerous Growth. Wiley Interdiscip Rev Membr Transp Signal (2011) 0.84
Metabotropic glutamate receptor 6 signaling enhances TRPM1 calcium channel function and increases melanin content in human melanocytes. Pigment Cell Melanoma Res (2013) 0.82
The glutamate agonist homocysteine sulfinic acid stimulates glucose uptake through the calcium-dependent AMPK-p38 MAPK-protein kinase C zeta pathway in skeletal muscle cells. J Biol Chem (2010) 0.78
Exosomes: The Link between GPCR Activation and Metastatic Potential? Front Genet (2016) 0.76
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A (1993) 2.62
Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. J Pathol (1999) 2.13
Squamous cell carcinoma of the penis. J Am Acad Dermatol (1996) 2.06
(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection. Neuropharmacology (2003) 1.82
Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum (1998) 1.63
Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur J Immunol (1995) 1.63
The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J Neurosci (1986) 1.61
Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. Leukemia (2011) 1.51
Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies. J Neuroimmunol (2007) 1.47
Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol (2009) 1.46
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway. Leukemia (2011) 1.45
Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci (1996) 1.43
The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP kinase/PI-3-kinase pathways. Eur J Neurosci (2001) 1.40
Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab (2001) 1.38
Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha 1-adrenoceptors. Proc Natl Acad Sci U S A (1986) 1.34
Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol Sci (2001) 1.31
Ipsilateral motor responses to focal transcranial magnetic stimulation in healthy subjects and acute-stroke patients. Stroke (2001) 1.29
Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci (2001) 1.29
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia (2008) 1.27
Primary classic Kaposi's sarcoma of the penis: report of a case and review. J Eur Acad Dermatol Venereol (2003) 1.27
Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet (1998) 1.27
Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus. J Neurochem (1986) 1.26
Mitotic signaling by beta-amyloid causes neuronal death. FASEB J (1999) 1.21
Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology (2005) 1.19
(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J Pharmacol Exp Ther (1999) 1.17
Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J Neurosci (1998) 1.13
Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells. Cell Death Differ (2005) 1.10
Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol Pharmacol (1996) 1.09
Expression of the Wnt inhibitor Dickkopf-1 is required for the induction of neural markers in mouse embryonic stem cells differentiating in response to retinoic acid. J Neurochem (2006) 1.08
Tryptophan 121 of subunit II is the electron entry site to cytochrome-c oxidase in Paracoccus denitrificans. Involvement of a hydrophobic patch in the docking reaction. J Biol Chem (1998) 1.08
PHCCC, a specific enhancer of type 4 metabotropic glutamate receptors, reduces proliferation and promotes differentiation of cerebellar granule cell neuroprecursors. J Neurosci (2004) 1.07
The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J (2000) 1.07
Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes (1999) 1.06
Expression of metabotropic glutamate receptors in the rat and human testis. J Endocrinol (2001) 1.06
Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance. Leukemia (2008) 1.05
The mGlu5 metabotropic glutamate receptor is expressed in zones of active neurogenesis of the embryonic and postnatal brain. Brain Res Dev Brain Res (2004) 1.04
Transcranial magnetic stimulation after pure motor stroke. Clin Neurophysiol (2002) 1.04
L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. Mol Pharmacol (2002) 1.04
Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep (2005) 1.03
Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Eur J Pharmacol (2000) 1.02
A silent mutation in exon 14 of the APC gene is associated with exon skipping in a FAP family. J Med Genet (2001) 1.02
Growth conditions differentially regulate the expression of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptor subunits in cultured neurons. J Neurochem (1993) 1.02
The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol (1993) 1.00
Retracted Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J Neurochem (2001) 1.00
Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice. Scand J Immunol (1995) 1.00
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. J Neurochem (2004) 0.99
Up-modulation of the expression of functional keratinocyte growth factor receptors induced by high cell density in the human keratinocyte HaCaT cell line. Cell Growth Differ (2000) 0.98
Growth factor-regulated pathways in epithelial cell proliferation. Am Rev Respir Dis (1990) 0.98
Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology (2000) 0.97
Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut (2006) 0.97
Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death. J Neurosci (2000) 0.97
Expression and coupling to polyphosphoinositide hydrolysis of group I metabotropic glutamate receptors in early postnatal and adult rat brain. Eur J Neurosci (1997) 0.96
Progenitor cells from the adult mouse brain acquire a neuronal phenotype in response to beta-amyloid. Neurobiol Aging (2005) 0.96
Effect of topical calcipotriol on inflammatory linear verrucous epidermal nevus. Pediatr Dermatol (1995) 0.95
Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Mol Pharmacol (1995) 0.95
Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective. Neuropharmacology (2000) 0.95
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry (2005) 0.95
Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology (2004) 0.94
Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells. Neuropharmacology (1995) 0.94
Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera. J Cell Biol (1995) 0.94
An open label evaluation of the efficacy of imiquimod 5% cream in the treatment of recalcitrant subungual and periungual cutaneous warts. J Dermatolog Treat (2003) 0.93
Deletions in exon 5 of the human rhodopsin gene causing a shift in the reading frame and autosomal dominant retinitis pigmentosa. Hum Genet (1992) 0.93
Endogenous activation of group-I metabotropic glutamate receptors is required for differentiation and survival of cerebellar Purkinje cells. J Neurosci (2001) 0.93
Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration. J Cereb Blood Flow Metab (1992) 0.93
Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptors. Neuropharmacology (1999) 0.93
Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis. J Neuroimmunol (2001) 0.93
beta-Amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol Aging (1993) 0.93
Activation of metabotropic glutamate receptors prevents neuronal apoptosis in culture. J Neurochem (1995) 0.92
Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells. J Neuroimmunol (2000) 0.91
Agminated lentiginosis: case report and review of the literature. Pediatr Dermatol (1994) 0.91
Desensitization of metabotropic glutamate receptors in neuronal cultures. J Neurochem (1991) 0.91
Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. Neuropharmacology (1999) 0.91
Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats. Neuropharmacology (2008) 0.91
Mechanisms underlying developmental changes in the expression of metabotropic glutamate receptors in cultured cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-D-aspartate receptors. Mol Pharmacol (1993) 0.91
Phencyclidine is a negative allosteric modulator of signal transduction at two subclasses of excitatory amino acid receptors. Proc Natl Acad Sci U S A (1987) 0.91
Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients. Allergy (2010) 0.90
Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas. Cell Death Differ (2012) 0.90
Protective role for type-1 metabotropic glutamate receptors against spike and wave discharges in the WAG/Rij rat model of absence epilepsy. Neuropharmacology (2011) 0.90
Cytochrome-c-binding site on cytochrome oxidase in Paracoccus denitrificans. Eur J Biochem (1998) 0.90
Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways. J Neurochem (2002) 0.90
Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication? Mol Psychiatry (2007) 0.90
Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia (1985) 0.90
Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Mol Cell Neurosci (2001) 0.90